Atlanta

Atlanta is the research capital of the Southeast, anchored by Georgia Tech’s engineering powerhouse, Emory University’s biomedical enterprise, and the headquarters of the Centers for Disease Control and Prevention. Melan works with corporate R&D teams, universities, and public health agencies across Atlanta to structure partnerships in AI, supply chain innovation, and biomedical research.


The Atlanta Research Partnership Landscape

Atlanta’s research ecosystem is led by the Georgia Institute of Technology, one of the top public engineering universities with over $1.2 billion in annual research expenditures across robotics, AI, cybersecurity, logistics, and advanced manufacturing. Emory University — with its School of Medicine, Rollins School of Public Health, and Winship Cancer Institute — attracts over $800 million in research funding annually. The Centers for Disease Control and Prevention is headquartered in Atlanta, employing thousands of researchers across infectious disease, global health, and epidemiology.

Corporate R&D is anchored by The Home Depot (supply chain technology), UPS (logistics and automation R&D in nearby Sandy Springs), Delta Air Lines (aviation technology), Coca-Cola (R&D across its global product portfolio), and Southern Company (energy research). The Georgia Research Alliance connects university research with industry partners across the state, and the ATDC incubator has launched hundreds of deep-tech startups.

Atlanta’s partnership opportunity lies at the intersection of logistics, public health, and AI — sectors where the region’s research capacity far exceeds its current corporate R&D engagement.


What Melan Does for Teams in Atlanta

For corporate R&D teams: We identify academic partners across Georgia Tech and Emory aligned with your priorities — from Georgia Tech’s leadership in supply chain AI, robotics, and cybersecurity to Emory’s strengths in vaccine development, clinical research, and global health. We structure partnerships that leverage Georgia’s R&D tax credits and the Georgia Research Alliance’s industry matching programs.

For public health and biomedical organizations: We help companies and foundations partner with the CDC and Emory on infectious disease research, structural biology, and clinical trial infrastructure. Our team understands the federal compliance landscape and partnership models unique to public health research.

For logistics and supply chain companies: Atlanta is the logistics capital of the US, with unparalleled academic research in supply chain optimization, autonomous logistics, and last-mile delivery systems. Melan helps companies access Georgia Tech’s Supply Chain & Logistics Institute and related research programs.


FAQ

How does Melan help companies partner with Georgia Tech or Emory?

We map Georgia Tech’s research centers and Emory’s clinical programs to identify alignment with your R&D priorities, then approach the appropriate industry liaison office with a pre-structured partnership framework.

What makes Atlanta unique for research partnerships?

Atlanta uniquely combines a top-5 engineering university, a leading biomedical research university, and the CDC — creating partnership opportunities at the intersection of AI, public health, and logistics that exist nowhere else.

Does Melan work with CDC research partners?

Yes. We help organizations navigate CDC partnership mechanisms — cooperative agreements, research collaboration agreements, and interagency contracts — to structure infectious disease, global health, and public health research collaborations.

How do I start a research partnership in Atlanta?

Contact Melan at themelan.com/contact-us. We discuss your R&D priorities and map the Atlanta research ecosystem to identify the right collaborators for your goals.


Ready to form a research partnership in Atlanta?

Melan helps corporate R&D teams, universities, and public health agencies across Atlanta structure successful research collaborations.

Speak to Our Team →

Have a unique project in mind? Let's talk.

Melan connects corporations, researchers, labs, and foundations with the technology partnerships they need to move further, faster.